Partition Dosimetry and Outcomes of Metastatic Neuroendocrine Tumors after Yttrium-90 Resin Microsphere Radioembolization-Reference-Cited by-同舟云学术

Partition Dosimetry and Outcomes of Metastatic Neuroendocrine Tumors after Yttrium-90 Resin Microsphere Radioembolization

Published:2023-10 Issue: Volume: Page:
ISSN:1051-0443
Container-title:Journal of Vascular and Interventional Radiology
language:en
Short-container-title:Journal of Vascular and Interventional Radiology

Author:

Doyle Patrick W.^ORCID,Workman C. Spencer^ORCID,Grice Jared V.,McGonigle Trey W.^ORCID,Huang Shi,Borgmann Anthony J.,Baker Jennifer C.^ORCID,Taylor Jason E.,Brown Daniel B.^ORCID

Funder

Sirtex Medical

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging

Reference33 articles.

1. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States;Yao;J Clin Oncol,2008

2. The evolving landscape of neuroendocrine tumors;Russo;Surg Oncol Clin N Am,2023

3. Therapeutic strategies for neuroendocrine liver metastases;Frilling;Cancer,2015

4. Influence of carcinoid syndrome on the clinical characteristics and outcomes of patients with gastroenteropancreatic neuroendocrine tumors undergoing operative resection;Kimbrough;Surgery,2019

5. Role of radioembolization in metastatic neuroendocrine tumors;Lewandowski;Cardiovasc Interv Radiol,2022

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective Dosimetry for Yttrium-90 Radioembolization with Resin Microspheres;Journal of Vascular and Interventional Radiology;2024-05

2. Radioembolization Working in Synergy with Chemotherapy in NET, but can Dosimetry Bring us Even Further?;CardioVascular and Interventional Radiology;2024-03-21